Frederiksberg, Denmark

Leonardo DeMaria

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Spotlight on Inventor Leonardo DeMaria: A Pioneer in Peroxygenase Variants

Introduction: Leonardo DeMaria, an innovative inventor based in Frederiksberg, DK, has made significant strides in the field of biotechnology with his focused research on peroxygenase variants. With one patent to his name, DeMaria exemplifies the role of inventors in advancing science and technology.

Latest Patents: The patent developed by DeMaria pertains to peroxygenase variants, which involve not only the variants themselves but also polynucleotides encoding these variants. His invention encompasses nucleic acid constructs, vectors, and host cells that incorporate the polynucleotides. Additionally, it outlines methods for utilizing these variants, highlighting their potential applications in various biotechnological processes.

Career Highlights: DeMaria's professional journey is marked by his association with Novozymes A/S, a leading company in the field of biotechnology known for its commitment to sustainable solutions. As an integral member of the Novozymes team, he has contributed to projects aimed at enhancing enzyme technologies, helping to drive innovation in the industry.

Collaborations: Throughout his career, DeMaria has collaborated with notable colleagues including Jesper Vind and Lars Henrik Oestergaard. These partnerships showcase the collaborative spirit within the scientific community, where ideas and expertise converge to advance research and development.

Conclusion: Leonardo DeMaria’s contributions to the field of biotechnology, particularly through his work on peroxygenase variants, underline the importance of innovation in addressing contemporary challenges. His dedication to research and company collaborations continues to shape the landscape of biotechnology, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…